Munc18-2 Deficiency Causes Familial Hemophagocytic Lymphohistiocytosis Type 5 and Impairs Cytotoxic Granule Exocytosis in Patient NK Cells

Total Page:16

File Type:pdf, Size:1020Kb

Munc18-2 Deficiency Causes Familial Hemophagocytic Lymphohistiocytosis Type 5 and Impairs Cytotoxic Granule Exocytosis in Patient NK Cells Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells Marjorie Côte, … , Alain Fischer, Geneviève de Saint Basile J Clin Invest. 2009;119(12):3765-3773. https://doi.org/10.1172/JCI40732. Research Article Immunology Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous autosomal recessive immune disorder characterized by the occurrence of uncontrolled activation of lymphocytes and macrophages infiltrating multiple organs. Disease-causing mutations in the perforin (PRF1; also known as FHL2), Munc13-4 (UNC13D; also known as FHL3), and syntaxin-11 (STX11; also known as FHL4) genes have been identified in individuals with FHL. These genes all encode proteins involved in the cytotoxic activity of lymphocytes. Here, we show that the gene encoding syntaxin-binding protein 2 (Munc18-2; official gene symbol STXBP2) is mutated in another subset of patients with FHL (designated by us as “FHL5”). Lymphoblasts isolated from these patients had strongly decreased STXBP2 protein expression, and NK cells exhibited impaired cytotoxic granule exocytosis, a defect that could be overcome by ectopic expression of wild-type STXBP2. Furthermore, we provide evidence that syntaxin-11 is the main partner of STXBP2 in lymphocytes, as its expression required the presence of STXBP2. Our work shows that STXBP2 deficiency causes FHL5. These data indicate that STXBP2 is required at a late step of the secretory pathway for the release of cytotoxic granules by binding syntaxin 11, another component of the intracellular membrane fusion machinery. Find the latest version: https://jci.me/40732/pdf Research article Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells Marjorie Côte,1,2 Mickaël M. Ménager,1,2 Agathe Burgess,1,2 Nizar Mahlaoui,3 Capucine Picard,2,4 Catherine Schaffner,1,2 Fahad Al-Manjomi,5 Musa Al-Harbi,5 Abdullah Alangari,6 Françoise Le Deist,7 Andrew R. Gennery,8 Nathalie Prince,1,2 Astrid Cariou,9 Patrick Nitschke,10 Ulrich Blank,11,12 Gehad El-Ghazali,13 Gaël Ménasché,1,2 Sylvain Latour,1,2 Alain Fischer,1,2,3 and Geneviève de Saint Basile1,2,4 1INSERM U768, Hôpital Necker-Enfants Malades, Paris, France. 2Faculté de Médecine, Université Paris Descartes, Paris, France. 3Service d’Immunologie et d’Hématologie Pédiatrique and 4Centre d’Etude des Déficits Immunitaires, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France. 5Department of Pediatric Hematology/Oncology, Prince Sultan Hematology Oncology Center, King Fahad Medical City, Riyadh, Saudi Arabia. 6Department of Pediatrics, College of Medicine, King Saudi University and King Khalid University Hospital, Riyadh, Saudi Arabia. 7Department of Microbiology and Immunology, CHU de Sainte Justine and University of Montréal, Montreal, Quebec, Canada. 8Newcastle General Hospital, Newcastle upon Tyne, United Kingdom. 9Genomic Core Facility, IFR94, and 10Informatic Core Facility, Université Paris Descartes, Paris, France. 11INSERM U699, Faculté de Medicine Paris 7, Site Xavier Bichat, Paris, France. 12Université Paris 7, Faculté de Médecine Paris Diderot — Site Xavier Bichat, Paris, France. 13Department of Immunology, King Fahad Medical City, Riyadh, Saudi Arabia. Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous autosomal recessive immune disorder characterized by the occurrence of uncontrolled activation of lymphocytes and macrophages infiltrating multiple organs. Disease-causing mutations in the perforin (PRF1; also known as FHL2), Munc13-4 (UNC13D; also known as FHL3), and syntaxin-11 (STX11; also known as FHL4) genes have been identified in individuals with FHL. These genes all encode proteins involved in the cytotoxic activity of lymphocytes. Here, we show that the gene encoding syntaxin-binding protein 2 (Munc18-2; official gene symbol STXBP2) is mutat- ed in another subset of patients with FHL (designated by us as “FHL5”). Lymphoblasts isolated from these patients had strongly decreased STXBP2 protein expression, and NK cells exhibited impaired cytotoxic gran- ule exocytosis, a defect that could be overcome by ectopic expression of wild-type STXBP2. Furthermore, we provide evidence that syntaxin-11 is the main partner of STXBP2 in lymphocytes, as its expression required the presence of STXBP2. Our work shows that STXBP2 deficiency causes FHL5. These data indicate that STXBP2 is required at a late step of the secretory pathway for the release of cytotoxic granules by binding syntaxin 11, another component of the intracellular membrane fusion machinery. Introduction or tumorigenic cells. Once cytotoxic cells have recognized their Familial hemophagocytic lymphohistiocytosis (FHL; MIM targets and formed a conjugate, cytotoxic activity is delivered in a 267700) is a genetically heterogeneous immune disorder of auto- multi-step process. This includes the polarization of the cytotoxic somal recessive inheritance. A hallmark of this condition consists granules containing perforin and granzymes toward the immu- in the occurrence of uncontrolled proliferation and activation of nologic synapse (IS) formed with the target, docking, priming, polyclonal T/NK lymphocytes and macrophages that infiltrate and fusion of the cytotoxic granules with the plasma membrane multiple organs including liver and spleen and the CNS. It causes so that release of their content induces target cell destruction by cytopenia and hyperferritinemia and has a fatal outcome (1). apoptosis (5–7). The inability of activated cytotoxic cells to clear Disease-causing mutations in the genes encoding perforin antigen-presenting targets results in sustained immune stimu- (PRF1; FHL2) (2), Munc13-4 (UNC13D; FHL3) (3), and syntaxin-11 lation, likely accounting for the unremitting polyclonal CD8+ (STX11; FHL4) (4) have been previously identified in FHL. They T cell activation and hyperimmune reaction that characterizes account for approximately 80% of FHL cases. These genes encode FHL. Along with perforin, which is critical for granzyme delivery proteins that are involved in the cytotoxic activity of lymphocytes. to target cells, Munc13-4 is essential in priming cytotoxic gran- Lymphocyte cytotoxic activity plays a major role in the defense ules docked at the IS, whereas STX11 regulates membrane fusion against viral infection and cancer by seeking out and killing infected events. In other patients however, the underlying molecular cause remains unknown. Here, we report that biallelic mutations in the Authorship note: Marjorie Côte and Mickaël M. Ménager contributed equally to gene encoding syntaxin binding protein 2 (STXBP2) account for this work. what we believe is a new genetic form of FHL. We have identified Conflict of interest: The authors have declared that no conflict of interest exists. 2 mutations that result in an absence or markedly decreased Citation for this article: J. Clin. Invest. 119:3765–3773 (2009). doi:10.1172/JCI40732. expression of STXBP2 in leukocytes from 8 patients. Remark- The Journal of Clinical Investigation http://www.jci.org Volume 119 Number 12 December 2009 3765 research article Table 1 jects. The mutations did not show any influence Phenotypes and genotypes observed in the 9 individuals carrying STXBP2 mutations on STXBP2 steady-state mRNA levels, which was normally abundant (Figure 2, A and B). Patient Origin Age at Age at final follow-up, Mutation Sequencing of the RT-PCR products confirmed diagnosis, mo mo (treatment) the mutations and enabled characterization of F1P1 Saudi Arabian 3.5 4A 1430C>T; P477L the new splice product for the individuals with F2P1 Saudi Arabian 1.5 30A 1430C>T; P477L the IVS14-1G>C mutation. Rather than leading F2P2 Saudi Arabian 1 16A 1430C>T; P477L to a premature stop codon, this splice mutation F3P1 Saudi Arabian 1 18 (on therapy) 1430C>T; P477L resulted in exchange of the first 17 aa of exon F3P2 Saudi Arabian 2 24 (HSCT) 1430C>T; P477L 15 by 19 new aa from the intronic sequence, F4P1 Palestinian 96 162 (HSCT) IVS 14-1 in frame with the last 20 aa of the exon 15 WT F5P1 Turkish 126 168 (on therapy) IVS 14-1 sequence (Figure 1B). F5P2 Turkish Asymptomatic 32 IVS 14-1 F6P1 Iranian 150 240B IVS 14-1 Defective expression of STXBP2. We assessed the expression of STXBP2 in lymphoblasts obtained APatient is deceased; cause of death was HLH. BPatient is deceased; cause of death was from F2P1, F2P2, F5P1, and F6P1. In a protein post-HSCT (HLH). blot analysis, STXBP2 protein was not found in lymphoblasts from F2P1 (Figure 2C) or F2P2 (data not shown) but was detected in lympho- ably, the latter mutation is associated with late-onset FHL. When blasts from F5P1 and F6P1, albeit at markedly lower levels than in STXBP2 is defective, patients’ NK cells conjugate with targets and control lymphoblasts (Figure 2C). These data indicate that FHL5 is polarize their cytotoxic granule toward the IS but are unable to associated with loss-of-function mutations in the STXBP2 gene. release cytotoxic granule contents. The phenotypic expression of FHL varied considerably as a func- tion of STXBP2 mutations, as shown in Table 1. In all patients with Results the P477L transition, FHL had a very early onset and rapidly led to STXBP2 mutations cause FHL. We studied a cohort of 6 consan- death in most cases. In contrast, FHL manifestations occurred sev- guineous families in which 10 individuals had been diagnosed eral years later in all patients with the
Recommended publications
  • Genome-Wide Rnai Screens Identify Genes Required for Ricin and PE Intoxications
    Developmental Cell Article Genome-Wide RNAi Screens Identify Genes Required for Ricin and PE Intoxications Dimitri Moreau,1 Pankaj Kumar,1 Shyi Chyi Wang,1 Alexandre Chaumet,1 Shin Yi Chew,1 He´ le` ne Chevalley,1 and Fre´ de´ ric Bard1,* 1Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673, Singapore *Correspondence: [email protected] DOI 10.1016/j.devcel.2011.06.014 SUMMARY In the lumen of the ER, these toxins are thought to interact with elements of the ER-associated degradation (ERAD) pathway, Protein toxins such as Ricin and Pseudomonas which targets misfolded proteins in the ER for degradation. exotoxin (PE) pose major public health challenges. This interaction is proposed to allow translocation to the cytosol Both toxins depend on host cell machinery for inter- without resulting in toxin degradation (Johannes and Ro¨ mer, nalization, retrograde trafficking from endosomes 2010). to the ER, and translocation to cytosol. Although Obviously, this complex set of membrane-trafficking and both toxins follow a similar intracellular route, it is membrane-translocation events involves many host proteins, some of which have already been described (Johannes and unknown how much they rely on the same genes. Ro¨ mer, 2010; Sandvig et al., 2010). Altering the function of these Here we conducted two genome-wide RNAi screens host proteins could in theory provide a toxin antidote. identifying genes required for intoxication and Consistently, inhibition of retrograde traffic by drugs such as demonstrating that requirements are strikingly Brefeldin A (Sandvig et al., 1991)(Yoshida et al., 1991) or Golgi- different between PE and Ricin, with only 13% over- cide A (Sa´ enz et al., 2009) and Retro-1 and 2 (Stechmann et al., lap.
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • Download Thesis
    This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ The Genetics and Spread of Amyotrophic Lateral Sclerosis Jones, Ashley Richard Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 07. Oct. 2021 THE GENETICS AND SPREAD OF AMYOTROPHIC LATERAL SCLEROSIS Ashley Richard Jones PhD in Clinical Neuroscience - 1 - Abstract Our knowledge of the genetic contribution to Amyotrophic Lateral Sclerosis (ALS) is rapidly growing, and there is increasing research into how ALS spreads through the motor system and beyond.
    [Show full text]
  • Regular Article
    From www.bloodjournal.org by guest on April 6, 2015. For personal use only. Regular Article IMMUNOBIOLOGY Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion Waldo A. Spessott,1 Maria L. Sanmillan,1 Margaret E. McCormick,1 Nishant Patel,2 Joyce Villanueva,3 Kejian Zhang,4 Kim E. Nichols,5 and Claudio G. Giraudo1 1Department of Pathology and Laboratory Medicine, and 2Division of Oncology, Department of Pediatrics, The Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; 3Division of Bone Marrow Transplant and Immune Deficiency, and 4Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; and 5Division of Cancer Predisposition, Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN Key Points Familial hemophagocytic lymphohistiocytosis (F-HLH) and Griscelli syndrome type 2 (GS) are life-threatening immunodeficiencies characterized by impaired cytotoxic T lymphocyte • Monoallelic STXBP2 mutations (CTL) and natural killer (NK) cell lytic activity. In the majority of cases, these disorders are affecting codon 65 impair caused by biallelic inactivating germline mutations in genes such as RAB27A (GS) and PRF1, lymphocyte cytotoxicity and UNC13D, STX11,andSTXBP2 (F-HLH). Although monoallelic (ie, heterozygous) mutations contribute to hemophagocytic have been identified in certain patients, the clinical significance and molecular mechanisms lymphohistiocytosis. by which these mutations influence CTL and NK cell function remain poorly understood. • Munc18-2R65Q/W mutant Here, we characterize 2 novel monoallelic hemophagocytic lymphohistiocytosis (HLH)- associated mutations affecting codon 65 of STXPB2, the gene encoding Munc18-2, a member proteins function in a dominant- of the SEC/MUNC18 family.
    [Show full text]
  • Clinical Spectrum Ofstx1b-Related Epileptic Disorders
    ARTICLE OPEN ACCESS Clinical spectrum of STX1B-related epileptic disorders Stefan Wolking, MD, Patrick May, PhD, Davide Mei, PhD, Rikke S. Møller, PhD, Simona Balestrini, PhD, Correspondence Katherine L. Helbig, MS, Cecilia Desmettre Altuzarra, MD, Nicolas Chatron, PhD, Charu Kaiwar, MD, Dr. Lerche Katharina Stohr,¨ MD, Peter Widdess-Walsh, MB, Bryce A. Mendelsohn, PhD, Adam Numis, MD, holger.lerche@ Maria R. Cilio, PhD, Wim Van Paesschen, MD, Lene L. Svendsen, MD, Stephanie Oates, MD, Elaine Hughes, MD, uni-tuebingen.de Sushma Goyal, MD, Kathleen Brown, MS, Margarita Sifuentes Saenz, MD, Thomas Dorn, MD, Hiltrud Muhle, MD, Alistair T. Pagnamenta, PhD, Dimitris V. Vavoulis, PhD, Samantha J.L. Knight, PhD, Jenny C. Taylor, PhD, Maria Paola Canevini, MD, Francesca Darra, MD, Ralitza H. Gavrilova, MD, Zoe¨ Powis, MS, Shan Tang, PhD, Justus Marquetand, MD, Martin Armstrong, PhD, Duncan McHale, PhD, Eric W. Klee, PhD, Gerhard J. Kluger, MD, Daniel H. Lowenstein, MD, Sarah Weckhuysen, PhD, Deb K. Pal, PhD, Ingo Helbig, MD, Renzo Guerrini, MD, Rhys H. Thomas, PhD, Mark I. Rees, PhD, Gaetan Lesca, PhD, Sanjay M. Sisodiya, PhD, Yvonne G. Weber, MD, Dennis Lal, PhD, Carla Marini, PhD, Holger Lerche, MD, and Julian Schubert, PhD Neurology® 2019;92:e1238-e1249. doi:10.1212/WNL.0000000000007089 Abstract Objective The aim of this study was to expand the spectrum of epilepsy syndromes related to STX1B, encoding the presynaptic protein syntaxin-1B, and establish genotype-phenotype correlations by identifying further disease- related variants. Methods We used next-generation sequencing in the framework of research projects and diagnostic testing. Clinical data and EEGs were reviewed, including already published cases.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • University of Florida Thesis Or Dissertation Formatting
    RNA-SEQ REVEALS NOVEL GENES AND PATHWAYS INVOLVED IN BOVINE MAMMARY INVOLUTION DURING THE DRY PERIOD AND UNDER ENVIRONMENTAL HEAT STRESS By BETHANY M. DADO SENN A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA 2018 © 2018 Bethany M. Dado Senn To my family, the true dairy enthusiasts ACKNOWLEDGMENTS To my advisor, mentor, and friend Dr. Jimena Laporta, I am humbled and grateful to have served as your graduate student as you provided invaluable advice and kindness throughout my projects. Your open-door policy has facilitated my growth both personally and professionally. Thank you for the opportunity to research lactation physiology, volunteer and teach, and pursue a degree at the University of Florida. I extend my appreciation to my committee members Dr. Geoffrey Dahl and Dr. Pete Hansen for utilizing their many years of experience to provide useful critiques and additional insight into my analysis and interpretations. Thank you to Dr. Hansen for the use of Ingenuity Pathway Analysis® and to Dr. Dahl for his heat stress expertise. I thank the faculty and staff in the Department of Animal Sciences at the University of Florida, especially Dr. Francisco Peñagaricano for his vital RNA- sequencing and statistical contribution to my thesis project. Further thanks to Dr. Corwin Nelson, Dr. Stephanie Wohlgemuth, and Dr. John Bromfield for use of lab space and research support. Special appreciation goes to Joyce Hayen, Pam Krueger, and Renee Parks-James and the UF Dairy Unit staff. I also express appreciation to the Animal Molecular and Cellular Biology program, the Brélan E.
    [Show full text]
  • Syntaxin Binding Mechanism and Disease-Causing Mutations In
    Syntaxin binding mechanism and disease-causing PNAS PLUS mutations in Munc18-2 Yvonne Hackmanna, Stephen C. Grahama,1,2, Stephan Ehlb, Stefan Höningc, Kai Lehmbergd, Maurizio Aricòe, David J. Owena, and Gillian M. Griffithsa,2 aCambridge Institute for Medical Research, University of Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0XY, United Kingdom; bCentre of Chronic Immunodeficiency, 79106 Freiburg, Germany; cInstitute for Biochemistry I and Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany; dDepartment of Paediatric Haematology and Oncology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany; and ePediatric Hematology Oncology Network, Istituto Toscana Tumori, 50139 Florence, Italy Edited* by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved October 11, 2013 (received for review July 18, 2013) Mutations in either syntaxin 11 (Stx11) or Munc18-2 abolish Munc18-2 belongs to the Sec1/Munc18-like (SM) protein cytotoxic T lymphocytes (CTL) and natural killer cell (NK) cytotox- family, whose members are all ∼600 residues long and are in- icity, and give rise to familial hemophagocytic lymphohistiocytosis volved in regulation of SNARE-mediated membrane fusion (FHL4 or FHL5, respectively). Although Munc18-2 is known to events (9, 10). The two closest homologs of Munc18-2 are interact with Stx11, little is known about the molecular mecha- Munc18-1, which is crucial for neurotransmitter secretion in nisms governing the specificity of this interaction or how in vitro neurons (11, 12), and Munc18-3, which is more widely expressed IL-2 activation leads to compensation of CTL and NK cytotoxicity. and is involved in Glut4 translocation (13).
    [Show full text]
  • De Novo Transcriptome Sequencing and Gene Expression Profiling With/Without B-Chromosome Plants of Lilium Amabile Doori Park, Jong-Hwa Kim, Nam-Soo Kim
    www.genominfo.org eISSN 2234-0742 Volume 17 number 3, September 30, 2019 Aims and scope Genomics & Informatics is the official journal of the Korea Genome Organization (http://kogo.or.kr). Its abbreviated title is Genomics Inform. It was launched in 2003 by the Korea Genome Organization. It aims at making a substantial contribution to the understanding of any areas of genomics or informatics. Its scope includes novel data on the topics of gene discovery, comparative genome analyses, molecular and human evolution, informatics, genome structure and function, technological innovations and applications, statistical and mathematical methods, cutting-edge genetic and physical mapping, next generation sequencing and de novo assembly, and other topics that present data where sequence information is used to address biological concerns. Especially, Clinical genomics section is for a short report of all kinds of genome analysis data from clinical field such as cancer, diverse complex diseases and genetic diseases. It encourages submission of the cancer panel analysis data for a single cancer patient or a group of patients. It also encourages deposition of the genome data into designated database. Genome archives section is for a short manuscript announcing the genetic information of recently sequenced prokaryotic and eukaryotic genomes. These genome archives data can make the rationale for sequencing a specific organism. It is published and distributed quarterly at the last dates of March, June, September, and December. All submitted manuscripts will be reviewed and selected for publication after single blind review process. All manuscripts must be submitted online through the e-submission system available from: http://submit.genominfo.org.
    [Show full text]
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name four and a half LIM domains 5 Gene Symbol FHL5 Organism Human Gene Summary The protein encoded by this gene is coordinately expressed with activator of cAMP-responsive element modulator (CREM). It is associated with CREM and confers a powerful transcriptional activation function. CREM acts as a transcription factor essential for the differentiation of spermatids into mature spermatozoa. There are multiple polyadenylation sites found in this gene. Alternative splicing results in multiple transcript variants encoding the same protein. Gene Aliases ACT, FLJ33049, KIAA0776, RP3-393D12.2, dJ393D12.2 RefSeq Accession No. NC_000006.11, NT_025741.15 UniGene ID Hs.632608 Ensembl Gene ID ENSG00000112214 Entrez Gene ID 9457 Assay Information Unique Assay ID qHsaCID0016446 Assay Type SYBR® Green Detected Coding Transcript(s) ENST00000326771, ENST00000450218, ENST00000541107 Amplicon Context Sequence GAAGGAGTTTGCTCACTACTGCAACTTTTGTAAGAAGGTGATAACTTCAGGTGGG ATAACATTTTGTGACCAGCTATGGCATAAAGAGTGTTTTCTGTGTAGTGGCTGT Amplicon Length (bp) 79 Chromosome Location 6:97053911-97058519 Assay Design Intron-spanning Purification Desalted Validation Results Efficiency (%) 96 R2 0.9991 cDNA Cq Target not expressed in universal RNA cDNA Tm (Celsius) Target not expressed in universal RNA gDNA Cq Target not expressed in universal RNA Page 1/5 PrimePCR™Assay Validation Report Specificity (%) No cross reactivity detected Information to assist with data interpretation is provided at the end of this report. Page 2/5
    [Show full text]
  • Identification of a Deletion in Stxbp2
    ndrom Sy es tic & e G n e e n G e f T o Coniglio et al., J Genet Syndr Gene Ther 2015, 6:3 Journal of Genetic Syndromes h l e a r n a DOI: 10.4172/2157-7412.1000276 r p u y o J & Gene Therapy ISSN: 2157-7412 Case Report Open Access “Identification of a Deletion in Stxbp2 Causative of Familial Hemophagocytic Lymphohistiocytosis Type 5” Coniglio ML1,3*, Cetica V1, Ciambotti B1,3, Grieve S2, Pantaleo M3, Rizzari C4, Sieni E1, Favre C1, Giglio S3, Griffiths GM2 and Aricò M5 1Department of Paediatric Oncohematology, Anna Meyer Children’s University Hospital, Florence, Italy 2Cambridge Institute for Medical Research, University of Cambridge Biomedical Campus, Addenbrooke’s Hospital, Cambridge, United Kingdom 3Genetics and Molecular Medicine Unit, Anna Meyer Children’s University Hospital, Florence, Italy 4Department of Pediatrics, Ospedale S. Gerardo, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy 5Azienda Sanitaria Provinciale, Ragusa, Italy Abstract Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening immune deficiency, characterized by a hyper-inflammatory syndrome. The familial form of HLH (FHL) is caused by mutations in genes associated with lymphocyte granule-mediated cytotoxicity. Mutations in Stxbp2 (Sintaxin binding protein 2) gene result in defect of Munc18-2 protein, the causative defect of the subtype defined as FHL5. Functional tests as intracytoplasmic expression of perforin and surface expression of CD107a, help to direct genetic analysis. Different mutations have been described in the FHL-related genes known so far (PRF1, UNC13-D, STX11, Stxbp2): missense, nonsense, splicing, regulatory, small deletions/insertions. Recently a pathogenic inversion of 253 KB upstream of the 3’ UNC13D gene has been reported.
    [Show full text]
  • Genome-Wide Characterization of Genetic Variants and Putative
    Boschiero et al. BMC Genomics (2018) 19:83 DOI 10.1186/s12864-018-4444-0 RESEARCH ARTICLE Open Access Genome-wide characterization of genetic variants and putative regions under selection in meat and egg-type chicken lines Clarissa Boschiero1,4* , Gabriel Costa Monteiro Moreira1,AlmasAraGheyas2, Thaís Fernanda Godoy1, Gustavo Gasparin1, Pilar Drummond Sampaio Corrêa Mariani1,MarcelaPaduan1, Aline Silva Mello Cesar1, Mônica Corrêa Ledur3 and Luiz Lehmann Coutinho1 Abstract Background: Meat and egg-type chickens have been selected for several generations for different traits. Artificial and natural selection for different phenotypes can change frequency of genetic variants, leaving particular genomic footprints throghtout the genome. Thus, the aims of this study were to sequence 28 chickens from two Brazilian lines (meat and white egg-type) and use this information to characterize genome-wide genetic variations, identify putative regions under selection using Fst method, and find putative pathways under selection. Results: A total of 13.93 million SNPs and 1.36 million INDELs were identified, with more variants detected from the broiler (meat-type) line. Although most were located in non-coding regions, we identified 7255 intolerant non-synonymous SNPs, 512 stopgain/loss SNPs, 1381 frameshift and 1094 non-frameshift INDELs that may alter protein functions. Genes harboring intolerant non-synonymous SNPs affected metabolic pathways related mainly to reproduction and endocrine systems in the white-egg layer line, and lipid metabolism and metabolic diseases in the broiler line. Fst analysis in sliding windows, using SNPs and INDELs separately, identified over 300 putative regions of selection overlapping with more than 250 genes. For the first time in chicken, INDEL variants were considered for selection signature analysis, showing high level of correlation in results between SNP and INDEL data.
    [Show full text]